药物发现筛选适应变化。 - Suppr

Suppr

超能文献

Drug discovery screen adapts to changes.

作者信息

Kerkvliet G J

出版信息

J Natl Cancer Inst. 1990 Jul 4;82(13):1087-8. doi: 10.1093/jnci/82.13.1087.

DOI:10.1093/jnci/82.13.1087

PMID:2359131

Abstract

摘要

相似文献

Drug discovery screen adapts to changes.

J Natl Cancer Inst. 1990 Jul 4;82(13):1087-8. doi: 10.1093/jnci/82.13.1087.

In defense of cell-line screening.

J Natl Cancer Inst. 1990 Jul 4;82(13):1083-5. doi: 10.1093/jnci/82.13.1083.

Current status and future directions of chemosensitivity testing.

Contrib Gynecol Obstet. 1994;19:179-94.

Gene targeting comes to top-down drug screens.

Trends Biotechnol. 2002 Mar;20(3):92-3. doi: 10.1016/s0167-7799(02)01912-1.

New colorimetric cytotoxicity assay for anticancer-drug screening.

J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12. doi: 10.1093/jnci/82.13.1107.

US cancer institute to overhaul tumour cell lines.

Nature. 2016 Feb 25;530(7591):391. doi: 10.1038/nature.2016.19364.

Drug discovery shifts toward rapid, mass screening.

J Natl Cancer Inst. 1996 Jun 5;88(11):704-5. doi: 10.1093/jnci/88.11.704.

Screening methods in antineoplastic drug discovery.

J Natl Cancer Inst. 1990 Jul 4;82(13):1082-3. doi: 10.1093/jnci/82.13.1082.

[History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro].

Bull Cancer. 1991;78(7):587-602.

Chemosensitivity assays: still eyeing the clinic.

J Natl Cancer Inst. 2012 Dec 5;104(23):1775-7. doi: 10.1093/jnci/djs499.

引用本文的文献

Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes.

J Cancer Res Clin Oncol. 1991;117(5):435-43. doi: 10.1007/BF01612764.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Drug discovery screen adapts to changes.

J Natl Cancer Inst. 1990 Jul 4;82(13):1087-8. doi: 10.1093/jnci/82.13.1087.

In defense of cell-line screening.

J Natl Cancer Inst. 1990 Jul 4;82(13):1083-5. doi: 10.1093/jnci/82.13.1083.

Current status and future directions of chemosensitivity testing.

Contrib Gynecol Obstet. 1994;19:179-94.

Gene targeting comes to top-down drug screens.

Trends Biotechnol. 2002 Mar;20(3):92-3. doi: 10.1016/s0167-7799(02)01912-1.

New colorimetric cytotoxicity assay for anticancer-drug screening.

J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12. doi: 10.1093/jnci/82.13.1107.

US cancer institute to overhaul tumour cell lines.

Nature. 2016 Feb 25;530(7591):391. doi: 10.1038/nature.2016.19364.

Drug discovery shifts toward rapid, mass screening.

J Natl Cancer Inst. 1996 Jun 5;88(11):704-5. doi: 10.1093/jnci/88.11.704.

Screening methods in antineoplastic drug discovery.

J Natl Cancer Inst. 1990 Jul 4;82(13):1082-3. doi: 10.1093/jnci/82.13.1082.

[History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro].

Bull Cancer. 1991;78(7):587-602.

Chemosensitivity assays: still eyeing the clinic.

J Natl Cancer Inst. 2012 Dec 5;104(23):1775-7. doi: 10.1093/jnci/djs499.

引用本文的文献

Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes.

J Cancer Res Clin Oncol. 1991;117(5):435-43. doi: 10.1007/BF01612764.